Reynders McVeigh Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-286	Closed	-$251K	–	204
2023 Q4	$251K	Hold	286	–	–	0.02%	176
2023 Q3	$235K	Buy	286 +5	+2%	+$3.93K	0.02%	180
2023 Q2	$202K	Sell	281 -1	-0.4%	-$771	0.01%	199
2023 Q1	$232K	Hold	282	–	–	0.02%	188
2022 Q4	$203K	Sell	282 -387	-58%	-$286K	0.01%	207
2022 Q3	$461K	Hold	669	–	–	0.04%	145
2022 Q2	$395K	Sell	669 -7	-1%	-$4.55K	0.03%	164
2022 Q1	$472K	Sell	676 -25	-4%	-$15.8K	0.03%	164
2021 Q4	$443K	Sell	701 -238	-25%	-$146K	0.03%	169
2021 Q3	$568K	Sell	939 -323	-26%	-$201K	0.03%	143
2021 Q2	$705K	Sell	1,262 -127	-9%	-$64.3K	0.04%	127
2021 Q1	$657K	Sell	1,389 -174	-11%	-$84.7K	0.04%	136
2020 Q4	$755K	Sell	1,563 -154	-9%	-$83.1K	0.05%	123
2020 Q3	$961K	Sell	1,717 -80	-4%	-$48.5K	0.07%	100
2020 Q2	$1.12M	Sell	1,797 -45	-2%	-$25.5K	0.1%	94
2020 Q1	$899K	Buy	1,842 +7	+0.4%	+$2.89K	0.1%	96
2019 Q4	$689K	Hold	1,835	–	–	0.07%	133
2019 Q3	$509K	Hold	1,835	–	–	0.05%	141
2019 Q2	$574K	Hold	1,835	–	–	0.06%	134
2019 Q1	$753K	Buy	1,835 +500	+37%	+$206K	0.08%	118
2018 Q4	$499K	Buy	+1,335	New	+$489K	0.07%	127